Frontlight ResearchEarly access
Myasthenia gravis trials in Latvia
2 of 2 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Not yet taking people in LatviaA Double-Blind, Randomized, Placebo-Controlled Study to Investigate the Safety and Efficacy of Aritinercept, a Dual BAFF/APRIL Inhibitor, in Patients with Generalized Myasthenia Gravis
- Where
- Riga
- Age
- 18 years and over
- People
- 45 worldwide
- Run by
- Aurinia Pharmaceuticals Inc.
See details and how to join2025-525127-27-00 - Phase 3Not yet taking people in LatviaA Phase 3 Study to Evaluate Claseprubart in Adults With Generalized Myasthenia Gravis (EMERGE)
- Where
- Riga
- Age
- 18 years to 80 years
- People
- 195 worldwide
- Run by
- Dianthus Therapeutics
See details and how to joinNCT07647510 · EU 2026-525298-38-00